Ms
Roxna
Kapadia

Patent Director

London Office

Life sciences

Telephone. +44 20 7776 5100
Email. [email protected]
Vcard
Linkedin

Experience

Roxna is a UK and European qualified patent attorney with in-depth knowledge and experience with viral cancer therapeutics, antibodies, stem cells, immunotherapy, genetics and food science. Roxna has in-house patent experience working at the small biotechnology company Oncolytics Biotech Inc. and at the multinational company General Electric Healthcare and Merck Sharp & Dohme.

Roxna has experience working before the EPO, UKIPO and WIPO, including drafting and filing applications, prosecution and EPO oppositions and appeals. Roxna also has extensive experience with IP due diligence, validity opinions and FTO analysis. Having worked both in house and in private practice, Roxna is well placed to provide business focused strategic intellectual property advice to her clients.

Roxna is a named inventor on a patent for a method of purifying viruses using gel permeation chromatography. Roxna developed and ran industry-focused intellectual property courses in London UK. In particular Roxna has taught Freedom to Operate courses for the Life Sciences and Pharmaceutical Industry.

Having grown up in Canada and worked in Switzerland, Roxna is fluent in English and French.

Specialisms

Industries

Services

Qualifications

Patent Attorney

Chartered (UK)
European

BSC

Microbiology and Immunology

MSC

Immunology

MSC

Management of Intellectual Property

Related News

Patentability of Simulations in Europe

Simulations offer a powerful tool in modern-day engineering. Subjecting designs to initial testing in a simulated environment will, for many designs, reduce costs owing to reduced needs to produce and …

Read article

Blockbuster blood thinning patent revoked

Summary Mr Justice Meade has revoked Bristol Myers Squibb’s (BMS) European patent No. EP1427415 (EP’415) and corresponding supplementary protection certificate (SPC) that relate to the compound Apixaban (ELIQUIS) for lack …

Read article
Event - 10th May 2022

The HGF IP in Healthcare Conference 2022

After a challenging couple of years, we are delighted to invite you to join us for HGF’s eighth annual IP in Healthcare Conference. We will review the latest intellectual property …

Event details
Event - 10th May 2022

HGF UPC events in Germany and Austria 2022

HGF is holding a webinar and an in-person event covering the UPC in Germany and Austria this Spring. The provisional phase of the Unified Patent Court (UPC) is now underway …

Event details
Event - 23rd March 2022

HGF webinar: Getting your first filing right

HGF hosted a webinar on Wednesday 23rd March on Getting your first filing right. One of the most often asked questions of patent attorneys is: “when should we file?” Both …

Event details
Event - 10th March 2022

Manufacturing & Supply Chain Conference 2022

HGF Patent Attorney Dr Robert Weinert-Aplin is attending and speaking at the Manufacturing & Supply Chain Conference on 10th March 2022 in Milton Keynes, UK. The Manufacturing & Supply Chain …

Event details

The Microbiome Times: ELIGO v SNIPR: a reflection on IP strategies in a competitive environment

HGF Partner and Patent Attorney Craig Thomson and Patent Director Dr Jennifer Bailey write an article for The Microbiome Times on ELIGO v SNIPR: a reflection on IP strategies in …

Read article

UPC could open its doors in 2022

With news that the Austrian parliament has ratified the Protocol on the provisional application of the Agreement on a Unified Patent Court on 2 December 2021, the Unified Patent Court …

Read article
See all updates

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.

Contact us